The European Medicines Agency has recommended that the marketing authorisation for Ionsys (fentanyl hydrochloride), an opioid analgesic produced by Janssen-Cilag International NV, be suspended because of a defect in the delivery system that could result in patients being overdosed. Janssen-Cilag is an affiliate of Johnson & Johnson.
